Pmh43 - Cost-Utility Analysis of Cariprazine Compared to Risperidone Among Patients With Negative Symptoms of Schizophrenia in Selected Central and Eastern European Countries

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1678
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pmh42 - Cost-Utility Analysis of Cariprazine Compared to Risperidone Among Patients With Negative Symptoms of Schizophrenia in Selected Nordic Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Estimating the Cost of Diabetes-Related Cardiovascular Complications in Selected Central and Eastern European Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cost-Of-Illness Studies in Nine Central and Eastern European Countries

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2019English

Central and Eastern European Countries (Information)

The Journal of Political Theory, Political Philosophy and Sociology of Politics Politeia
2000English

Negative Symptoms of Schizophrenia Are Associated With Abnormal Effort-Cost Computations

Biological Psychiatry
Biological Psychiatry
2013English

Evolution of Presence of Predominant Negative Symptoms in Patients With Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Credit Rating and the Cost of Public Debt Service in Central and Eastern European Countries From 2005 to 2017

Gospodarka Narodowa
2019English

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

Frontiers in Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy